Pillstats
Rx only · Capsule, Extended Release · Oral

Dexmethylphenidate Hydrochloride

Brands: Focalin Xr · Dexmethylphenidate Hydrochloride

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US78 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers9 labelers
Packages86
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 66 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.44$2.88$4.32$5.76Jul 2025Jan 2026Jun 2026
$2.607
Latest avg · Jun 17, 2026
-45%
Since Jul 23, 2025
8
Active US suppliers
39%
Top-2 supplier share*

Who makes it8 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sandoz Incunknown16SUPPLYING
Bryant Ranch Prepackrepackager15SUPPLYING
Par Health USA, LLCunknown10SUPPLYING
Lannett Company, Inc.unknown8SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown8SUPPLYING
Granules Pharmaceuticals Incunknown8SUPPLYING
Camber Pharmaceuticals, Inc.unknown8SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown7SUPPLYING
Novartis Pharmaceuticals Corporationunknown6EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.